These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19230387)

  • 1. Esterase profile and analysis of structure-inhibitor selectivity relationships for homologous phosphorylated 1-hydroperfluoroisopropanols.
    Makhaeva GF; Serebryakova OG; Boltneva NP; Galenko TG; Aksinenko AY; Sokolov VB; Martynov IV
    Dokl Biochem Biophys; 2008; 423():352-7. PubMed ID: 19230387
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of esterases in man.
    Williams FM
    Clin Pharmacokinet; 1985; 10(5):392-403. PubMed ID: 3899454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The esterase-like activity of serum albumin may be due to cholinesterase contamination.
    Chapuis N; Brühlmann C; Reist M; Carrupt PA; Mayer JM; Testa B
    Pharm Res; 2001 Oct; 18(10):1435-9. PubMed ID: 11697469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Features of inhibition of butyrylcholinesterase and carboxylesterase hydrolysis of fluoroanhydride esters by beta,beta-diphenylethylphosphonic acid].
    Brestkin AP; Nikol'skaia EB; Kuznetsova LP; Efimtseva EA; Fridland SV
    Dokl Akad Nauk; 1994 Dec; 339(6):816-8. PubMed ID: 7888994
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of butyrylcholinesterase by organophosphorus compounds: a quantitative structure-activity analysis.
    Barbato F; Cappello B; Silipo C; Vittoria A
    Farmaco Sci; 1982 Aug; 37(8):519-36. PubMed ID: 7128809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organophosphorus compounds and esterases: current research topics concerning the toxicity of and protection against organophosphates.
    Reiner E
    Arh Hig Rada Toksikol; 2001 Nov; 52(3):323-31. PubMed ID: 11770330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprophen: a substrate and inhibitor of butyrylcholinesterase and carboxylesterases.
    Rush RS; Ralston JS; Wolfe AD
    Biochem Pharmacol; 1985 Jun; 34(12):2063-8. PubMed ID: 4004924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths].
    Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN
    Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726
    [No Abstract]   [Full Text] [Related]  

  • 9. New insights on molecular interactions of organophosphorus pesticides with esterases.
    Mangas I; Estevez J; Vilanova E; França TC
    Toxicology; 2017 Feb; 376():30-43. PubMed ID: 27311923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organophosphorus compound esterase profiles as predictors of therapeutic and toxic effects.
    Makhaeva GF; Radchenko EV; Palyulin VA; Rudakova EV; Aksinenko AY; Sokolov VB; Zefirov NS; Richardson RJ
    Chem Biol Interact; 2013 Mar; 203(1):231-7. PubMed ID: 23123251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in activities of mouse esterase and sensitivities to DFP and sarin toxicity.
    Tuovinen K; Kaliste-Korhonen E; Hänninen O
    Gen Pharmacol; 1997 Sep; 29(3):333-5. PubMed ID: 9378236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of dialkyl(alpha-carbomethoxy-beta,beta,beta-trifluoro- ethyl) phosphates with mammalian esterases].
    Makhaeva GF; Fetisov VI; Sokolov VB; Iankovskaia VL; Goreva TV
    Bioorg Khim; 1987 Jan; 13(1):33-7. PubMed ID: 3566818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diisopropylfluorophosphate on brain acetylcholinesterase, butyrylcholinesterase, and neurotoxic esterase in rats.
    Lim DK; Hoskins B; Ho IK
    Biomed Environ Sci; 1989 Sep; 2(3):295-304. PubMed ID: 2610946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Features of inhibiting butyrylcholinesterase and carboxylesterase hydrolysis with fluoranhydride esters of beta,beta-diphenylethylphosphonic acid].
    Brestkin AP; Efimtseva EA; Kuznetsova LP; Nikol'skaia EB; Fridland SV
    Biokhimiia; 1996 Mar; 61(3):472-9. PubMed ID: 8724606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phosphorus atom availability and mechanism enzyme inhibiting effect of organophosphorous inhibitors of cholinesterases of various origin. Results of conformational and correlational analysis].
    Rozengart EV; Shestakova NN; Prokator SO; Basova NE
    Zh Evol Biokhim Fiziol; 1999; 35(1):36-9. PubMed ID: 10399821
    [No Abstract]   [Full Text] [Related]  

  • 16. Esterases in quail (Coturnix coturnix). Physicochemical and developmental aspects.
    Tsitsiloni OE; Veini M; Haritos AA
    Comp Biochem Physiol B; 1993 Dec; 106(4):1009-14. PubMed ID: 8299343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The peptidase site of butyrylcholinesterase is distinct from the esterase site].
    Chatonnet A; Masson P
    C R Acad Sci III; 1984; 299(13):529-34. PubMed ID: 6208983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenyl valerate esterase activity of human butyrylcholinesterase.
    Mangas I; Vilanova E; Estévez J
    Arch Toxicol; 2017 Oct; 91(10):3295-3305. PubMed ID: 28299395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of esterases reacting with organophosphorus compounds.
    Reiner E; Pavković E; Radić Z; Simeon V
    Chem Biol Interact; 1993 Jun; 87(1-3):77-83. PubMed ID: 8393750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of O,O-diethylphosphoryl oximes as inhibitors of cholinesterases and substrates of phosphotriesterases.
    Leader H; Vincze A; Manisterski B; Rothschild N; Dosoretz C; Ashani Y
    Biochem Pharmacol; 1999 Aug; 58(3):503-15. PubMed ID: 10424771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.